Bromomethane

Bromomethane

SCHEMBL7086772

CBr.Cc1ccc(C(O)(C(=O)OCC(=CO)c2ccccc2)c2ccc(C)cc2)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
CHRM2 P08172 4/20 0.40
CHRM1 P11229 4/20 0.40
CHRM3 P20309 4/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
POLB P06746 3/20 0.40
CHRM4 P08173 2/20 0.39
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HTT P42858 1/20 0.36
USP2 O75604 1/20 0.36
CHRM5 P08912 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085430 0.97 NPC1 (0.43) NPC1RAB9ACHRM2CHRM1CHRM3
Bromomethane SCHEMBL7081929 0.89 KMT2A (0.44) CHRM2CHRM1CHRM3KMT2AMEN1
Bromomethane SCHEMBL118164 0.89 CHRM2 (0.39) NPC1RAB9ACHRM2CHRM1CHRM3
Bromomethane SCHEMBL14142659 0.88 CES2 (0.41) NPC1RAB9ACHRM2CHRM1CHRM3
SCHEMBL7082002 0.87 HPGD (0.43) NPC1RAB9ACHRM2CHRM1CHRM3
SCHEMBL7082997 0.85 CES2 (0.43) NPC1RAB9ACHRM2CHRM1CHRM3
SCHEMBL14142347 0.85 PDPK1 (0.46) NPC1RAB9ACHRM2CHRM1CHRM3
SCHEMBL931372 0.85 CHRM2 (0.39) NPC1RAB9ACHRM2CHRM1CHRM3
SCHEMBL7085988 0.85 MEN1 (0.43) NPC1RAB9ACHRM2CHRM1CHRM3
Bromomethane SCHEMBL7084864 0.83 PDPK1 (0.39) NPC1RAB9ACHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1328524-B1 NOVEL ANTICHOLINERGICS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2012-12-12 EP disclosed
EP-1328524-A2 NOVEL ANTICHOLINERGICS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2003-07-23 EP disclosed
WO-2002032898-A2 NOVEL ANTICHOLINERGICS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-04-25 WO disclosed